11P Senescent immune phenotype (SIP) status that predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients is not associated with chronic type I IFN signature

M. Naigeon,C. de Oliveira,F-X. Danlos, B. Duchemann, P. Saulnier, L. Boselli,J-M. Jouniaux, F. Griscelli, A. Marabelle, L. Lacroix, L. Cassard, B. Besse, N. Chaput

Annals of Oncology(2021)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要